Michael D. Jain

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma”.

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2020)10.1200/jco.19.02104

N/A

0.997DataRank · unranked

767 citations

Michael D. Jain, Lei Feng, Jay Y. Spiegel, Armin Ghobadi, Yi Lin +23 more

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0056

N/A

0.557DataRank · unranked

40 citations

Sae Bom Lee, Michael D. Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski +28 more

Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.06.038

N/A

0DataRank · unranked

53 citations

Timothy J. Robinson, Austin J. Sim, Xuefeng Wang, Biwei Cao, Julio C. Chávez +11 more

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

Cancer Medicine(2021)10.1002/cam4.3664

N/A

0DataRank · unranked

35 citations

Reena Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain +17 more

Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.018

N/A

0DataRank · unranked

14 citations

Ariel Perez Perez, Christina A. Bachmeier, Rahul Mhaskar, Julio C. Chávez, Bijal Shah +7 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more

Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma

Blood(2022)10.1182/blood.2021015008

N/A

0DataRank · unranked

87 citations

Bachisio Ziccheddu, Caroline A. Coughlin, Rawan Faramand, Anthony J. Griswold, Kayla Reid +11 more

Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.023

N/A

0DataRank · unranked

44 citations

Anna Barata, Jennifer M. Logue, Anuhya Kommalapati, Kelly A. Hyland, Ashley M. Nelson +15 more

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.006

N/A

0DataRank · unranked

312 citations

Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed +26 more

How I Treat Refractory CRS and ICANS Following CAR T-cell Therapy

Blood(2023)10.1182/blood.2022017414

N/A

0DataRank · unranked

145 citations

Melody Smith, Nirali N. Shah, Michael D. Jain

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

American Journal of Hematology(2023)10.1002/ajh.27056

N/A

0DataRank · unranked

48 citations

Yucai Wang, Omar Albanyan, Javier Muñoz, Pierre Sesques, Gloria Iacoboni +15 more

Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009426

N/A

0DataRank · unranked

29 citations

Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed Hossain, Michael D. Jain +5 more

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Blood Advances(2023)10.1182/bloodadvances.2023011489

N/A

0DataRank · unranked

26 citations

Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin +21 more

Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.18.572239

N/A

0DataRank · unranked

1 citations

Yuan Ren, Ronak Kundalia, Hasan Alhaddad, Zhihua Chen, Gerald Wallace +17 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management

The Lancet Haematology(2024)10.1016/s2352-3026(24)00077-2

N/A

0DataRank · unranked

105 citations

Michael D. Jain, Nirali N. Shah, Miguel‐Angel Perales, Marion Subklewe, Kai Rejeski

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0DataRank · unranked

74 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more

Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.09.013

N/A

0DataRank · unranked

4 citations

Anna Barata, Xiaoyin Li, Nathaly Irizarry‐Arroyo, Michael D. Jain, Taylor Welniak +19 more

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.11.15.623836

N/A

0DataRank · unranked

0 citations

Dhanvantri Chahar, Michael D. Jain, Alexandra M. Poos, Michael Durante, Bachisio Ziccheddu +19 more

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Blood Advances(2025)10.1182/bloodadvances.2024014476

N/A

0DataRank · unranked

10 citations

Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel +21 more

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01338-1

N/A

0DataRank · unranked

8 citations

Sandeep Raj, Michael D. Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann +26 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011807

N/A

0DataRank · unranked

4 citations

Michael D. Jain, Meghan Menges, Ling Cen, Jerald Noble, Reginald Atkins +20 more

CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma

Research Square(2025)10.21203/rs.3.rs-3481746/v1

N/A

0DataRank · unranked

3 citations

Sae Bom Lee, Yun Pyo Kang, Justin C. Boucher, Jay K. Mandula, Emiliano Roselli +25 more

The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicities

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.03.06.641668

N/A

0DataRank · unranked

1 citations

Yongliang Zhang, Nolan Beatty, Shannon McSain, Cooper J. Sailer, Muhammad Junaid Tariq +10 more

Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.12.025

N/A

0DataRank · unranked

10 citations

Ambuj Kumar, Hamza Hashmi, Franco Garcia, Constantine Logothetis, Alicia Darwin +14 more

Subjective cognition in chimeric antigen receptor T-cell therapy recipients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7020

N/A

0DataRank · unranked

1 citations

Aasha I. Hoogland, Kelly A. Hyland, Anuhya Kommalapati, Reena Jayani, Nathalie E. Irizarry-Arroyo +8 more